GNI Group Ltd. (2160.T)
JPY 3460.0
(2.37%)
JPY 3460.0
(2.37%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 22.43 Billion JPY | 52.13% |
| 2022 | 14.74 Billion JPY | 32.96% |
| 2021 | 11.08 Billion JPY | 34.78% |
| 2020 | 8.22 Billion JPY | 28.66% |
| 2019 | 6.39 Billion JPY | 53.34% |
| 2018 | 4.17 Billion JPY | 93.67% |
| 2017 | 2.15 Billion JPY | 92.75% |
| 2016 | 1.11 Billion JPY | 44.03% |
| 2015 | 775.72 Million JPY | 147.4% |
| 2014 | 313.54 Million JPY | 1717.99% |
| 2013 | 17.24 Million JPY | -50.17% |
| 2012 | 34.61 Million JPY | 93.45% |
| 2011 | 17.89 Million JPY | -91.52% |
| 2010 | 211.01 Million JPY | 0.0% |
| 2008 | 32.14 Million JPY | -68.42% |
| 2007 | 101.79 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 4.83 Billion JPY | 2.22% |
| 2024 Q1 | 4.73 Billion JPY | 11.26% |
| 2023 Q2 | 9.12 Billion JPY | 151.12% |
| 2023 Q3 | 5.42 Billion JPY | -40.55% |
| 2023 FY | 22.43 Billion JPY | 52.13% |
| 2023 Q1 | 3.63 Billion JPY | -6.63% |
| 2023 Q4 | 4.25 Billion JPY | -21.58% |
| 2022 Q1 | 3.38 Billion JPY | 22.51% |
| 2022 Q3 | 3.83 Billion JPY | 5.43% |
| 2022 Q4 | 3.89 Billion JPY | 1.49% |
| 2022 FY | 14.74 Billion JPY | 32.96% |
| 2022 Q2 | 3.63 Billion JPY | 7.45% |
| 2021 Q3 | 2.64 Billion JPY | 17.02% |
| 2021 Q1 | 3.41 Billion JPY | 42.4% |
| 2021 Q2 | 2.26 Billion JPY | -33.77% |
| 2021 FY | 11.08 Billion JPY | 34.78% |
| 2021 Q4 | 2.76 Billion JPY | 4.32% |
| 2020 Q1 | 1.74 Billion JPY | 2.19% |
| 2020 Q2 | 1.89 Billion JPY | 8.12% |
| 2020 Q3 | 2.18 Billion JPY | 15.76% |
| 2020 Q4 | 2.39 Billion JPY | 9.62% |
| 2020 FY | 8.22 Billion JPY | 28.66% |
| 2019 Q3 | 1.65 Billion JPY | -2.64% |
| 2019 Q1 | 1.32 Billion JPY | 16.3% |
| 2019 FY | 6.39 Billion JPY | 53.34% |
| 2019 Q2 | 1.7 Billion JPY | 28.93% |
| 2019 Q4 | 1.71 Billion JPY | 3.17% |
| 2018 Q2 | 973.38 Million JPY | 11.65% |
| 2018 Q3 | 1.18 Billion JPY | 22.18% |
| 2018 Q1 | 871.78 Million JPY | -8.18% |
| 2018 FY | 4.17 Billion JPY | 93.67% |
| 2018 Q4 | 1.13 Billion JPY | -4.46% |
| 2017 Q1 | 286.42 Million JPY | -32.09% |
| 2017 FY | 2.15 Billion JPY | 92.75% |
| 2017 Q3 | 604.33 Million JPY | 92.94% |
| 2017 Q2 | 313.21 Million JPY | 9.36% |
| 2017 Q4 | 949.48 Million JPY | 57.11% |
| 2016 Q1 | 260.53 Million JPY | 13.78% |
| 2016 Q2 | 198.39 Million JPY | -23.85% |
| 2016 FY | 1.11 Billion JPY | 44.03% |
| 2016 Q4 | 421.78 Million JPY | 78.32% |
| 2016 Q3 | 236.53 Million JPY | 19.23% |
| 2015 FY | 775.72 Million JPY | 147.4% |
| 2015 Q2 | 192.58 Million JPY | 15.75% |
| 2015 Q1 | 166.37 Million JPY | 5.8% |
| 2015 Q4 | 228.98 Million JPY | 21.94% |
| 2015 Q3 | 187.77 Million JPY | -2.5% |
| 2014 Q3 | 95.31 Million JPY | 149.57% |
| 2014 FY | 313.54 Million JPY | 1717.99% |
| 2014 Q4 | 157.25 Million JPY | 64.99% |
| 2014 Q1 | 22.79 Million JPY | 14.22% |
| 2014 Q2 | 38.19 Million JPY | 67.52% |
| 2013 FY | 17.24 Million JPY | -50.17% |
| 2013 Q4 | 19.95 Million JPY | 344.5% |
| 2013 Q1 | -7.36 Million JPY | -200.51% |
| 2013 Q2 | 160 Thousand JPY | 102.17% |
| 2013 Q3 | 4.49 Million JPY | 2706.25% |
| 2012 Q1 | 15.34 Million JPY | 630.02% |
| 2012 Q4 | 7.32 Million JPY | 435.66% |
| 2012 Q3 | -2.18 Million JPY | -115.45% |
| 2012 FY | 34.61 Million JPY | 93.45% |
| 2012 Q2 | 14.12 Million JPY | -7.96% |
| 2011 Q1 | 5.48 Million JPY | -94.46% |
| 2011 Q3 | 1.47 Million JPY | -83.25% |
| 2011 FY | 17.89 Million JPY | -91.52% |
| 2011 Q4 | 2.1 Million JPY | 42.22% |
| 2011 Q2 | 8.82 Million JPY | 60.85% |
| 2010 Q1 | 434 Thousand JPY | 0.0% |
| 2010 FY | 211.01 Million JPY | 0.0% |
| 2010 Q4 | 99.09 Million JPY | -7.3% |
| 2010 Q3 | 106.89 Million JPY | 2229.95% |
| 2010 Q2 | 4.58 Million JPY | 957.14% |
| 2009 Q3 | 5.71 Million JPY | 194.46% |
| 2009 Q1 | -283 Thousand JPY | -100.91% |
| 2009 Q2 | -6.04 Million JPY | -2036.04% |
| 2008 FY | 32.14 Million JPY | -68.42% |
| 2008 Q4 | 31.16 Million JPY | 1826.27% |
| 2008 Q3 | 1.61 Million JPY | 554.49% |
| 2008 Q2 | -356 Thousand JPY | 0.0% |
| 2007 FY | 101.79 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | -1092.326% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -27832.128% |
| Linical Co., Ltd. | 3.77 Billion JPY | -493.686% |
| Trans Genic Inc. | 2.24 Billion JPY | -897.267% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -22730.248% |
| Soiken Holdings Inc. | 2.48 Billion JPY | -803.618% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | -1635.338% |
| AnGes, Inc. | -3.06 Billion JPY | 831.781% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 12721.78% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | -132.111% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | -4236.261% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | -20116.279% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | -1446.342% |
| CanBas Co., Ltd. | -984 Million JPY | 2379.591% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | -5626.65% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | -1254.418% |
| Chiome Bioscience Inc. | 398.59 Million JPY | -5527.561% |
| Kidswell Bio Corporation | 1.03 Billion JPY | -2058.124% |
| PeptiDream Inc. | 17.21 Billion JPY | -30.272% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -73192.518% |
| Ribomic Inc. | -10.5 Million JPY | 213689.554% |
| SanBio Company Limited | -14.5 Million JPY | 154755.095% |
| Healios K.K. | 108 Million JPY | -20669.606% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 6578157.185% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 38089.322% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 1483643.32% |
| StemRIM | -44.34 Million JPY | 50678.762% |
| CellSource Co., Ltd. | 3.18 Billion JPY | -604.275% |
| FunPep Company Limited | -680.28 Million JPY | 3397.311% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -32291.588% |
| Stella Pharma Corporation | 217.29 Million JPY | -10222.771% |
| TMS Co., Ltd. | -6.95 Million JPY | 322850.719% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | -7030.946% |
| Cuorips Inc. | 9.63 Million JPY | -232805.981% |
| K Pharma,Inc. | 910 Million JPY | -2364.964% |
| Takara Bio Inc. | 25.45 Billion JPY | 11.886% |
| ReproCELL Incorporated | 1.1 Billion JPY | -1930.481% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | -1776.995% |
| StemCell Institute Inc. | 1.57 Billion JPY | -1323.404% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | -1245.776% |
| CellSeed Inc. | 107.15 Million JPY | -20833.391% |